• Member Login
  • Become a Member
  • Database Search
IATI - Israel Advanced Technology Industries
IATI - Israel Advanced Technology Industries
IATI Database Life Science Companies Biotechnology CellCure Neurosciences Ltd

CellCure Neurosciences Ltd

CellCure Neurosciences Ltd
Website: http://www.cellcureneurosciences.com

Category: Biotechnology
Sub-category: Tissue Engineering & Cell Therapy
Medical field: Ophthalmology
Est.: 2005
Stage: Pre-Clinical

Cell Cure Neurosciences Ltd. (Cell Cure) is focused on the development of cell therapies for retinal and neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. Both of these cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company's OpRegen® product is intended for use in RPE transplantations in patients with age related macular degeneration (AMD) and is expected to be among the first hESC based products to reach clinical trials.

Contact Person Charles Irving, CEO
General Email sara@cellcure.co.il
Address Cellcure Neurosciences Ltd, POB 12247 Jerusalem 91121
Phone +972-2-572-2000
Fax +972-2-642-9856


To update your company data, click here.
| Terms of Use | Privacy Policy | Sitemap